Ubrigene

CDMO focused on providing services for cell therapy and AAV vector products

placeBeijing, Beijing, China calendar_todayFounded 2015 groups500 employees language ubrigene.com

Social engagement

Social engagement: 3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

14 investors on record; lead investors include Addor Capital, IDG Capital, Juming Venture Capital, Huagai Capital.

Investor typeCountShare
Venture capital536%
Private equity536%
Other / undisclosed429%

Recent activity

1 Jul 2026
Event
FIFA WorldCup 2026
26 Jun 2026
Event
ISSCR 2026
22 Jun 2026
Event
Next-Generation PBMC-to-iPSC Reprogramming Webinar
Coming soon